Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1949 1
1952 1
1954 1
1959 2
1965 1
1970 1
1971 1
1973 1
1979 1
1985 5
1986 7
1987 5
1988 1
1989 2
1990 5
1991 6
1992 13
1993 17
1994 17
1995 22
1996 9
1997 23
1998 10
1999 20
2000 21
2001 26
2002 38
2003 51
2004 58
2005 80
2006 106
2007 166
2008 196
2009 239
2010 290
2011 333
2012 475
2013 507
2014 582
2015 660
2016 731
2017 852
2018 919
2019 1123
2020 1179
2021 1428
2022 1717
2023 1702
2024 1950
2025 2250
2026 570

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,399 results

Results by year

Filters applied: . Clear all
Page 1
Chinese Immune Multi-Omics Atlas.
Yin J, Zheng Y, Huang Z, Zhou W, Yuan Y, Cai P, Bai Y, Yang S, Gao Y, Duan S, Wang Y, Xu Z, Zhang W, Zhang X, Wei Y, Huang Y, Liu Y, Wang W, Yang T, Zhang Z, Chen X, Zhang X, Lv J, Li F, Zhang Y, Zeng G, Wang X, Ma W, Hou G, Hao S, Liu C, Lai Y, Liu P, Wang B, Li Y, Zhang W, Gao P, Xie J, Esteban MA, Gu Y, Liu X, Ji J, Qi T, Liu B, Wang H, Zhao Y, Yang X, Wang X, Chen R, Yang J, Yin Y, Wang J, Cao Y, Xu X, Liu L, Jin X, Liu C. Yin J, et al. Among authors: yin y. Science. 2026 Jan 8;391(6781):eadt3130. doi: 10.1126/science.adt3130. Epub 2026 Jan 8. Science. 2026. PMID: 41505528
Parkinson's disease as a somato-cognitive action network disorder.
Ren J, Zhang W, Dahmani L, Gordon EM, Li S, Zhou Y, Long Y, Huang J, Zhu Y, Guo N, Jiang C, Zhang F, Bai Y, Wei W, Wu Y, Bush A, Vissani M, Wei L, Oehrn CR, Morrison MA, Zhu Y, Zhang C, Hu Q, Yin Y, Cui W, Fu X, Zhang P, Wang W, Ji GJ, He J, Wang K, Fan D, Wang Z, Kimberley T, Little S, Starr PA, Richardson RM, Li L, Wang M, Wang D, Dosenbach NUF, Liu H. Ren J, et al. Among authors: yin y. Nature. 2026 Feb 4. doi: 10.1038/s41586-025-10059-1. Online ahead of print. Nature. 2026. PMID: 41639440
Charting brain morphology in international healthy and neurological populations.
Zhuo Z, Chai L, Wang Y, Gao P, Xu X, Ai L, Ao F, Bai Y, Bai Y, Cole JH, Bao H, Cai Q, Cao J, Chen F, Chen F, Chen K, Chen Y, Cheng D, Cui Z, Dai H, Deng D, Du Y, Fan G, Fu Y, Gao Z, Gou L, Guo C, Guo M, Guo Y, Han X, He H, Hou Y, Hu B, Hu J, Huang CC, Huang P, Lei J, Li HJ, Li J, Li J, Li K, Li S, Li W, Li X, Li Y, Li Y, Li Y, Li Y, Li Y, Liang P, Liao H, Lin CP, Liu J, Liu J, Liu W, Liu Y, Lu S, Luo J, Luo Y, Lui S, Ma H, Mao N, Meng L, Meng L, Qian Y, Qiu J, Rong M, Shao J, Shen Q, Shi Y, Shu Z, Sun J, Tian D, Tu Y, Wang F, Wang J, Wang J, Wang W, Wang X, Wang Y, Wang Y, Wang Z, Weng J, Wu F, Wu Y, Wu Y, Wu H, Xia X, Xu C, Xu J, Xu J, Xu R, Xu S, Yan P, Yang R, Yin S, Yin X, Yin Y, Yu R, Yuan Z, Zhang F, Zhang H, Zhang J, Zhang N, Zhang R, Zhang T, Zhang Y, Zhang Z, Zhang Z, Zhang Z, Zhao J, Zhao L, Zhao X, Zhao X, Zhao X, Zhe X, Zhou F, Zhu J, Zhu L, Li K, Duan X, Duan Y, Zuo XN, Liu Y. Zhuo Z, et al. Among authors: yin y. Nat Neurosci. 2026 Feb;29(2):420-434. doi: 10.1038/s41593-025-02144-5. Epub 2025 Dec 29. Nat Neurosci. 2026. PMID: 41461930
AI-guided personalized predictions on myopia progression and interventions.
Liu S, Lu Y, Li X, Chen X, Sun Z, Li G, Wang K, Wu W, Xu H, Li H, Hu C, Zou Z, Zhang M, Zhang X, Lu W, Yin Y, Qu J, Zhang K, Chen J. Liu S, et al. Among authors: yin y. NPJ Digit Med. 2026 Jan 12;9(1):129. doi: 10.1038/s41746-025-02308-4. NPJ Digit Med. 2026. PMID: 41526629 Free PMC article.
Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial.
Yin Y, Zhang Q, Sun T, Hao C, Wang Z, Yang J, Wang Y, Shi Y, Sun J, Ouyang Q, Su H, Wu J, Gan L, Han M, Gao L, Wang X, Zhao B, Li H, Zhao J, Yang H, Ning F, Tian F, Zhang J, Sun H, Niu Z, Zong H, Zang A, Wang X, Qian X, Wu S, Nie J, He L, Cheng Y, Hao Y, Zhai Y, Li H, Wang J, Wei S, Li M, Liu Y, Guo H, Hu Q, Liu L, Han X, Luo R, Ni M, Tang X, Zhai Z, Ding M, Wang H, Shen P, Wang X, Liu L, Chen W, Liu G, Cai Z, Jiang Z. Yin Y, et al. Signal Transduct Target Ther. 2025 Dec 18;10(1):414. doi: 10.1038/s41392-025-02475-6. Signal Transduct Target Ther. 2025. PMID: 41413016 Free PMC article. Clinical Trial.
16,399 results
You have reached the last available page of results. Please see the User Guide for more information.